Holen Sie sich die Stockscreener-App
1.30
0.38%
0.00
Schlusskurs vom Vortag:
$1.30
Offen:
$1.29
24-Stunden-Volumen:
100.63K
Relative Volume:
0.13
Marktkapitalisierung:
$130.76M
Einnahmen:
$31.20M
Nettoeinkommen (Verlust:
$-21.68M
KGV:
-5.3235
EPS:
-0.2442
Netto-Cashflow:
$-15.52M
1W Leistung:
-5.43%
1M Leistung:
-8.10%
6M Leistung:
-36.96%
1J Leistung:
-54.84%
1-Tages-Spanne:
$1.28
$1.31
1-Wochen-Bereich:
$1.28
$1.419
52-Wochen-Spanne:
$1.24
$3.59
Stereotaxis Inc Stock (STXS) Company Profile
Firmenname
Stereotaxis Inc
Sektor
Telefon
314-678-6100
Adresse
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, RMD, MDLN
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
STXS
Stereotaxis Inc
|
1.305 | 130.26M | 31.20M | -21.68M | -15.52M | -0.2442 |
ISRG
Intuitive Surgical Inc
|
353.20 | 123.70B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
180.17 | 48.78B | 21.37B | 1.41B | 3.07B | 3.9437 |
ALC
Alcon Inc
|
69.04 | 33.41B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
219.25 | 31.89B | 5.54B | 1.52B | 1.74B | 10.37 |
MDLN
Medline Inc
|
34.76 | 30.44B | 29.14B | 1.07B | 1.05B | 1.1956 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-16 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2024-01-10 | Eingeleitet | ROTH MKM | Buy |
| 2022-07-12 | Eingeleitet | Aegis Capital | Buy |
| 2022-06-23 | Eingeleitet | B. Riley Securities | Buy |
| 2022-01-05 | Eingeleitet | Craig Hallum | Buy |
| 2022-01-05 | Eingeleitet | Loop Capital | Buy |
| 2021-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2020-09-08 | Eingeleitet | Northland Capital | Outperform |
| 2020-04-09 | Eingeleitet | Cowen | Outperform |
| 2020-04-07 | Eingeleitet | Lake Street | Buy |
Alle ansehen
Stereotaxis Inc Aktie (STXS) Neueste Nachrichten
Stereotaxis Stock Price Forecast. Should You Buy STXS? - StockInvest.us
Stereotaxis: A Real Product Story, But The Stock Already Prices In Success (NYSE:STXS) - Seeking Alpha
July launch by Stereotaxis achieves 70 cases treating full arrhythmia spectrum - Traders Union
A Hungarian hospital treated over 70 heart patients with robots in just over a month - Stock Titan
Stereotaxis Inc (STXS) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Citizens JMP Maintains Stereotaxis(STXS.US) With Buy Rating, Cuts Target Price to $3 - Moomoo
Stereotaxis (STXS) Q2 2026 Earnings Call Transcript - AOL.com
Stereotaxis (STXS) Update: Ends Lower by 1.39% at $1.42 in the Current Update; Market Levels: the $1.35 to $1.49 Range Remains in Focus at the CloseAdvance Decline Volume - dars.gov.et
New >5% shareholder emerges in Stereotaxis (STXS) stock - Stock Titan
Stereotaxis, Inc. momentum grows in robotic electrophysiology as sector approaches inflection point - Traders Union
Robot performs 26 cataract surgeries with surgeon control - AOL.com
STXS|Stereotaxis Inc|Price:1.395|Chg%:+0.035 - TradingKey
Stereotaxis Number of Employees 2026 | Employee Count & Headcount Data - Revelio Labs
Stereotaxis, Inc. engages with medical leaders at KCHRS event - Traders Union
Stereotaxis, Inc. introduces MAGiC ablation tip for efficient energy delivery - Traders Union
Stereotaxis, Inc. SEC Filing (Aug 14, 2026) - Stock Titan
Stereotaxis (STXS) Stock Sees Little Reward For Recurring Revenue Progress - Sahm
STXS Q2 2026 Earnings: Narrow EPS Beat Overshadowed by 4.11% Share SlideTangible Book Value - vinanet.vn
Stereotaxis, Inc. completes Robocath deal as GenesisX gains first U.S. customer - Traders Union
Stereotaxis, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Stereotaxis Q2 Earnings Call Highlights - TradingView
Stereotaxis Inc. (STXS) Reports Q2 Loss, Lags Revenue Estimates - Yahoo Finance
Is Stereotaxis Inc (STXS) Undervalued Despite Q2 Revenue Miss? G - GuruFocus
Stereotaxis robotic catheter sales surge 270% in Q2 despite revenue miss - scanx.trade
Transcript : Stereotaxis, Inc., Q2 2026 Earnings Call, Aug 11, 2026 - marketscreener.com
Stereotaxis Reports 2026 Second Quarter Financial Results & Business Updates - The Manila Times
Stereotaxis Q2 revenue misses estimates, dragged by system decline - tradingview.com
Stereotaxis, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Stereotaxis’ First U.S. GenesisX Robot to Be Installed This Fall - Stock Titan
BRIEF-Stereotaxis Q2 Revenue USD 7.67 Million Vs. IBES Estimate USD 8.35 Million - TradingView
Stereotaxis Inc (STXS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Stereotaxis Inc (RJR1.DU) Analyst insights, Price targets and Recommendations - Yahoo Finance Australia
Enterprise value to revenue forward of Stereotaxis, Inc. – FWB:RJR1 - TradingView
Stereotaxis, Inc. brings GenesisX robot for community heart health education in St. Louis - tradersunion.com
Stereotaxis (STXS) Projected to Release Quarterly Earnings on Tuesday - marketbeat.com
Stereotaxis Inc (STXS) Institutional Confidence - TradingKey
STXS Q1 2026 Earnings: EPS Misses Estimates Amid Limited Financial VisibilityHealthcare Earnings Report - vinanet.vn
Stereotaxis Inc (STXS) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Stereotaxis Inc (STXS) Cash Flow - TradingKey
Stereotaxis Inc (STXS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Stereotaxis Inc (STXS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Stereotaxis Inc (STXS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
STXS|Stereotaxis Inc|Price:1.260|Chg%:-0.070 - TradingKey
STXS Q1 2026 Earnings: EPS Miss Sparks 8.5% Stock DeclineEarnings Yield Spread - Vinanet
STXS|Stereotaxis Inc|Price:1.300|Chg%:+0.010 - TradingKey
Stereotaxis Inc (STXS) Valuation: PE, PB & Fair Value Analysis - TradingKey
Stereotaxis Inc (STXS) Balance Sheet - TradingKey
Stereotaxis, Inc. Revenue Breakdown – AMEX:STXS - TradingView
Stereotaxis Inc. (STXS) Stock Price | Live Quotes & Charts | AMEX - timothysykes.com
Stereotaxis, Inc. (STXS) stock price, news, quote and history - Yahoo Finance UK
Stereotaxis to Discuss Robotic Intervention Results on Aug. 11 - Stock Titan
Finanzdaten der Stereotaxis Inc-Aktie (STXS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.12%
0.62%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):